Spectrum: Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
BOSTON-(BUSINESS WIRE)-Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announced today... Read MoreThe post Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update appeared first on citybiz.
Read full article »
Spectrum is a Nevada-based biopharmaceutical company that acquires, develops and commercializes novel therapeutics for the treatment of cancer.
Read more